SCHEMBL29988927

SCHEMBL29988927

COc1ccc(CC(=O)Nc2ccc(C(=O)NCC(=O)NS(C)(=O)=O)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
MEN1 O00255 5/20 0.61
KMT2A Q03164 5/20 0.61
MAPT P10636 2/20 0.61
POLB P06746 3/20 0.58
CTDSP1 Q9GZU7 1/20 0.58
CA12 O43570 1/20 0.58
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
CA9 Q16790 1/20 0.58
SMN1; SMN2 Q16637 4/20 0.57
LMNA P02545 3/20 0.57
MAPK1 P28482 2/20 0.56
RAB9A P51151 2/20 0.55
KDM4E B2RXH2 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
HTT P42858 1/20 0.51
PKM P14618 1/20 0.49
NPC1 O15118 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5183704 0.80 ALDH1A1 (0.75) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL7697158 0.79 EGFR (0.67) ALDH1A1MEN1KMT2AMAPTCA12
SCHEMBL30034264 0.79 SMN1; SMN2 (0.88) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL9995867 0.77 ALDH1A1 (0.79) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL14490974 0.74 NPC1 (0.69) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL3923158 0.74 SMN1; SMN2 (0.78) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL13185621 0.74 SMN1; SMN2 (1.00) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL2453779 0.74 SMN1; SMN2 (0.78) ALDH1A1MEN1KMT2AMAPTCA12
SCHEMBL16562293 0.73 ALDH1A1 (0.79) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL13167586 0.73 SMN1; SMN2 (0.72) ALDH1A1MEN1KMT2AMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11530205-B2 GLP-1 receptor modulators RECEPTOS LLC (US) 2022-12-20 US disclosed
EP-3615524-B1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC (US) 2022-11-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11530205-B2 GLP-1 receptor modulators GLP1R, GIPR, GCGR ALDH1A1 3744/4885MEN1 262/4885KMT2A 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.